preeclampsia
Trinity Biotech to Acquire Metabolomics Dx for $1.3M in Cash and Stock
Trinity plans to bring to market in 2025 Metabolomics Diagnostics' PrePsia test that can be used to determine preeclampsia risk in the 12th week of pregnancy.
QuidelOrtho Gets Health Canada Approval for Triage Preeclampsia Test
The approval is for an assay to detect biomarkers that may indicate the likelihood of developing preeclampsia during a pregnancy.
The Foundation for the National Institutes of Health is leading a public-private collaboration that could help make available in the US tests that are sold in Europe.
New data has demonstrated that DNA fragment size differences that discriminate preeclampsia from healthy controls can be detected using a lower-cost PCR method.
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
A ratio of the two biomarkers detected by the 30-minute clinical chemistry assays can be used for prognosis and treatment of preeclampsia.